European Neuromuscular Centre Mid-Career Mentoring Programme Now Open
The European Neuromuscular Centre (ENMC) Mid-Career Mentoring Programme is now open for the third round of mentee candidates!
About the Programme
The programme has been developed for people who wish to seek mentoring in order to become independent researchers and/or potential future leaders in the NMD field. These individuals will be at the stage in their careers where they are developing their own research plans and are establishing their research teams and collaborative networks worldwide.
Feedback from first-year mentees
First-year mentees completed a survey on their mentoring programme experience, with results showing that the programme was extremely beneficial: the mentees were satisfied, well-matched with their mentors, and saw improvement in skills they wanted to improve (such as networking, self-confidence, delegation of work, communicating and presenting themself and securing a good work-life balance). NMD4C members who have participated in the programme as mentors in the past include Dr. James Dowling, Dr. Cynthia Gagnon, and Dr. Hanns Lochmüller.
How to apply for the ENMC Mentoring Programme
If you are interested in the mentoring programme, please find here a link to the ENMC webpage and to videos illustrating the experiences of one mentee and one mentor, which may inspire you to apply as a mentee or mentor in this ENMC programme!
The applications can be submitted to with a deadline of 1 July 2023: Guidelines – ENMC.
Read next...
Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG
Nov 25-28, 2025 | Join us at Hope on the Horizon to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!
2026 Awards Now Open for Nominations!
We’re proud to recognize outstanding achievements across the neuromuscular research community with our Three awards: Publication of the Year, Early Career Biomedical/Clinical Researchers of the Year.
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.